Literature DB >> 28834858

Diuretic Resistance in Acute Decompensated Heart Failure: A Challenging Clinical Conundrum.

Brent N Reed1, Sandeep Devabhakthuni.   

Abstract

Most patients with acute decompensated heart failure (ADHF) present with signs and symptoms of volume overload, and those with a significant history of diuretic exposure may demonstrate varying degrees of diuretic resistance. Although this phenomenon is commonly reported, no consensus definition exists and recommendations regarding an optimal therapeutic approach remain limited. Optimizing the use of intravenous (IV) loop diuretic therapy is the most common initial approach, and therapy may be augmented by the addition of a thiazide-type diuretic or an IV vasodilator. Patients whose resistance to diuretic therapy is due to low cardiac output may require inotropic therapy, and other options (eg, ultrafiltration and vasopressin antagonists) may be considered in select populations. The purpose of this review is to describe diuretic resistance and its underlying mechanisms in ADHF, as well as the most commonly employed strategies for overcoming it. A stepwise approach to managing volume overload in patients with ADHF and diuretic resistance is also provided.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28834858     DOI: 10.1097/CNQ.0000000000000173

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  3 in total

Review 1.  Loop diuretics in chronic heart failure: how to manage congestion?

Authors:  Justas Simonavičius; Christian Knackstedt; Hans-Peter Brunner-La Rocca
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 2.  Efficacy of Nondiuretic Pharmacotherapy for Improving the Treatment of Congestion in Patients with Acute Heart Failure: A Systematic Review of Randomised Controlled Trials.

Authors:  Abdelrahman N Emara; Noha O Mansour; Mohamed Hassan Elnaem; Moheb Wadie; Inderpal Singh Dehele; Mohamed E E Shams
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

3.  Metolazone Add-On Therapy in Heart Failure: A Cohort Study from Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF).

Authors:  Farzad Rahimi; Mehrbod Vakhshoori; Maryam Heidarpour; Fatemeh Nouri; Kiyan Heshmat-Ghahdarijani; Mohammad Fakhrolmobasheri; Davood Shafie
Journal:  Crit Care Res Pract       Date:  2021-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.